#lcmes - Twitter Hashtag

Cancer Research Institute @CancerResearch

almost 5 years ago

Updated data from a phase 3 clinical trial at @bmsnews suggests that the combination of nivolumab and ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma. #lcmes https://t.co/5pSBZZNR7r

0

3

1

0

Oncology Times @OncologyTimes

almost 5 years ago

Year In Review: 2021 #Mesothelioma Treatments & Clinical Trials: https://t.co/rgYF45rbhD #researchhiglights #oncology #lcmes

OncologyTimes's tweet photo. Year In Review: 2021 #Mesothelioma Treatments & Clinical Trials: https://t.co/rgYF45rbhD #researchhiglights #oncology
#lcmes https://t.co/jMWGjwIlcw

0

2

0

ESMO - Eur. Oncology

@myESMO

almost 5 years ago

Novel concepts on the horizon for the diagnosis and treatment of #mesothelioma as demonstrated in the CheckMate 743 trial presented at #ESMO21. Results commented by @MdCurioni 👉https://t.co/0C9VmhrjZq #lcsm #lcmes #tcell #immunotherapy #medTwitter #rarecancer